Biotin-peg5-nh-boc

Catalog No. :
ACPUMN685
CAS No. :
189209-28-7
Molecular Formula :
C27H50N4O9S
Molecular Weight :
606.78

IUPAC Name:tert-butyl (19-oxo-23-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9,12,15-pentaoxa-18-azatricosyl)carbamate

Biotin-peg5-nh-boc structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$376.00Login to see priceInquiryInquiry
250mg96%$682.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBiotin-peg5-nh-boc
IUPAC Nametert-butyl (19-oxo-23-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9,12,15-pentaoxa-18-azatricosyl)carbamate
MDL No.MFCD30527395
Molecular FormulaC27H50N4O9S
Molecular Weight606.78
SMILES[H][C@]12CS[C@H]([C@]1(NC(N2)=O)[H])CCCCC(NCCOCCOCCOCCOCCOCCNC(OC(C)(C)C)=O)=O
InChI KeyRDDPDJYPEFICFA-FIXSFTCYSA-N
SynonymBiotin-PEG5-NH-Boc;tert-Butyl (19-oxo-23-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-3,6,9,12,15-pentaoxa-18-azatricosyl)carbamate;5,8,11,14,17-Pentaoxa-2,20-diazapentacosanoic acid, 25-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-21-oxo-, 1,1-dimethylethyl ester;Biotin-PEG5-CH2CH2NH-Boc
CAS No.189209-28-7

Synthetic Route by SureRoute

1. ACPUMN685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLOCF120 route compound structure diagram
    ACLOCF120189209-27-6 In Stock
  2. Plus
  3. ACBWUK036 route compound structure diagram
    ACBWUK03658-85-5 In Stock
  4. Then
  5. ACPUMN685 route product structure diagram
    ACPUMN685189209-28-7
Inquiry

2. ACPUMN685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLOCF120 route compound structure diagram
    ACLOCF120189209-27-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUMN685 route product structure diagram
    ACPUMN685189209-28-7
Inquiry

Comments (0)